Table 1.
Baseline characteristics
| Variables | Number of patients (%) |
|---|---|
| Age (years) | |
| Median (IQR) | 65 (61 to 68) |
| Sex | |
| Female | 9 (69 %) |
| Male | 4 (31 %) |
| Primary site | |
| Gall bladder | 3 (23 %) |
| Bile duct | 9 (69 %) |
| Ampulla | 1 (8 %) |
| ECOG PS | |
| 0 | 9 (69 %) |
| 1 | 4 (31 %) |
| T-stage | |
| T1 | 1 (8 %) |
| T2 | 0 (0 %) |
| T3 | 8 (62 %) |
| T4 | 1 (8 %) |
| TX | 3 (23 %) |
| N-stage | |
| N0 | 2 (15 %) |
| N1 | 5 (38 %) |
| N2 | 1 (8 %) |
| NX | 5 (38 %) |
| M-stage | |
| M0 | 1 (8 %) |
| M1a | 10 (77 %) |
| MX | 2 (15 %) |
| Tumour differentiation | |
| Well/Moderately differentiated | 6 (46 %) |
| Poorly differentiated | 6 (46 %) |
| Not specified | 1 (8 %) |
| Previous treatment | |
| None | 5 (38 %) |
| Chemotherapy | 0 (0 %) |
| Surgery | 8 (62 %) |
| Radiotherapy | 0 (0 %) |
| Other | 0 (0 %) |
| 2+ types | 0 (0 %) |
| Biliary Stent Insertions | 7 (54 %) |
aSites of metastasis: 8 patients had liver metastases, 3 had peritoneum, 2 had lung. Two patients had other metastasis: one had small bowel and the other had coeliac lymph node positive gastric lymph node